Company intelligence / Profile preview

Setara Biosciences

San Diego, California, United Statessetarabiosciences.com ↗
Ownership
Private
Development stage
Other
01

Overview

Setara Biosciences is a private, clinical-stage biotechnology company developing genetics-driven precision medicines for severe rare diseases and related larger-population indications. The company was formed in 2026 to advance the non-ABS-1230 pipeline remaining after Jazz Pharmaceuticals acquired Actio Biosciences. Its lead program, STAR-0871, is an oral small-molecule inhibitor of TRPV4 being developed for Charcot-Marie-Tooth disease type 2C and overactive bladder. Setara also has undisclosed discovery-stage programs addressing genetic epilepsies, migraine, and other rare genetic diseases. The company launched with a $90 million Series A financing and is led by Actio Biosciences co-founders David Goldstein and David Breckenridge.

Therapeutic areas
UrologyNeurology
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

1 asset

STAR-0871

Unknown
03

Partnerships

Jazz Pharmaceuticals (shareholder following the Actio Biosciences transaction; Setara was formed to advance Actio's remaining pipeline)

Beyond the preview

Go deeper on Setara Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Setara Biosciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call